Attitudes and practices about fertility preservation discussions among young adults with cancer treated at a comprehensive cancer center: patient and oncologist perspectives

Author(s):  
John M. Salsman ◽  
Betina Yanez ◽  
Mallory A. Snyder ◽  
Alexis R. Avina ◽  
Marla L. Clayman ◽  
...  
2017 ◽  
Vol 6 (2) ◽  
pp. 229-234 ◽  
Author(s):  
Mary Peavey ◽  
Sara Arian ◽  
William Gibbons ◽  
Karen Lu ◽  
David Gershenson ◽  
...  

2018 ◽  
Vol 2 (S1) ◽  
pp. 37-37
Author(s):  
Stefanie M. Thomas ◽  
Jemily Malvar ◽  
Henry Tran ◽  
Jared Shows ◽  
David R. Freyer

OBJECTIVES/SPECIFIC AIMS: Low cancer clinical trial (CCTs) enrollment may contribute to the poor survival improvement for adolescents and young adults (AYAs, aged 15–39 years) with cancer. Treatment site is thought to exacerbate this problem. This study evaluated whether differences in CCT availability explain lower CCT enrollment depending on treatment site for AYAs. METHODS/STUDY POPULATION: This prospective, observational cohort study was conducted at an academic children’s hospital and an adult cancer hospital, 2 affiliated sites within a NCI-designated Comprehensive Cancer Center over 13 months. In consecutive AYA patients newly diagnosed with cancer at both site, it was determined whether an appropriate CCT existed nationally, was available locally, and if enrollment occurred. The proportions of AYAs in these categories were compared by site using the χ2 test. RESULTS/ANTICIPATED RESULTS: Among 152 consecutive AYA patients, 68 and 84 were treated at the children’s hospital and adult cancer hospital, respectively. AYAs treated at the children’s hospital had similar CCT existence nationally compared with AYAs treated at the adult hospital [36/68 (52.9%) vs. 45/84 (53.6%), p=0.938]. However, a significantly higher percentage of children’s hospital treated AYAs than adult hospital treated AYAs had an available CCT [30/68 (44.1%) vs. 14/84 (16.7%), p<0.001]. Enrollment percentages were similarly low in both groups [8/68 (11.8%) vs. 6/84 (7.1%), p=0.327]. DISCUSSION/SIGNIFICANCE OF IMPACT: Significantly fewer AYAs treated at the adult hospital had a CCT available, but national existence was similar at both sites. This suggests that institutional barriers to opening CCT have more importance at adult centers.


2019 ◽  
Vol 28 (4) ◽  
pp. 544-550 ◽  
Author(s):  
Maria Vittoria Dieci ◽  
Cristina Ghiotto ◽  
Caterina Barbieri ◽  
Gaia Griguolo ◽  
Carlo Saccardi ◽  
...  

2017 ◽  
Vol 25 (5) ◽  
pp. 1579-1586 ◽  
Author(s):  
Stacy D. Sanford ◽  
Jennifer L. Beaumont ◽  
Mallory A. Snyder ◽  
Jennifer Reichek ◽  
John M. Salsman

Cancer ◽  
2015 ◽  
Vol 121 (24) ◽  
pp. 4398-4406 ◽  
Author(s):  
Chelsea L. Collins ◽  
Jemily Malvar ◽  
Ann S. Hamilton ◽  
Dennis M. Deapen ◽  
David R. Freyer

2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 135-135
Author(s):  
Michael E Auster ◽  
Michelle Janania Martinez ◽  
Jean-Pierre Blaize ◽  
Lakene Raissa Djoufack Djoumessi ◽  
Brian Warnecke ◽  
...  

135 Background: Young adults undergoing cancer treatment often face increased risk of infertility. Despite current ASCO guidelines recommending prompt fertility preservation education, knowledge about prevalence and barriers to oncofertility care is lacking. This is particularly true for patients in medically underserved and minority communities. This study sought to characterize the utilization of oncofertility counseling in a major Hispanic serving institution. Methods: Retrospective chart review was performed at the University of Texas Mays Cancer Center San Antonio and included patients diagnosed with testicular, early stage breast cancer or leukemia/lymphoma between age 18-40 from 2015-2019. Demographic data including ethnicity, race, funding, zip code were collected. Chart reviewed determined if fertility counseling was provided and which patients elected for oncofertility treatments. Results: Of 304 evaluable patients, only 120 had documented fertility discussions. There was no significant difference in the odds of counseling between gender, funding, or race. However, the odds of receiving fertility discussions was higher in non-Hispanic whites compared to Hispanic whites with an odds ratio of 1.94 (P value of 0.032). For those who opted for fertility treatment there was no statistically significant difference between diagnosis, race, ethnicity, or payment status. Conclusions: Our study demonstrates oncofertility discussions occur in a relatively small proportion of eligible patients. Additionally, patients who self -identify as Hispanic were less likely to receive fertility discussions. This study demonstrates that more research is necessary to evaluate the barriers to fertility discussion and treatment, and how these barriers result in decreased oncofertility education in Hispanic young adults with curable malignancies. [Table: see text]


2019 ◽  
Vol 10 (02) ◽  
pp. 75-76
Author(s):  
Ine Schmale

Das Armamentarium zur Behandlung des Nierenzellkarzinoms (RCC) hat sich um effektive Therapien erweitert, durch die der Therapiealgorithmus komplett umgestellt werden musste. Prof. Michael B. Atkins vom Georgetown-Lombardi Comprehensive Cancer Center, Washington DC/USA, und Prof. Daniel Y. C. Heng vom Tom Baker Cancer Center, Calgary/Kanada, teilten beim ASCO-GU ihre Einschätzung zur optimalen Behandlung des Nierenzellkarzinoms in der Erst- und Zweitlinientherapie für das Jahr 2019.


Suchttherapie ◽  
2011 ◽  
Vol 12 (S 01) ◽  
Author(s):  
A Jähne ◽  
C Schulz ◽  
J Balmford ◽  
J Leifert ◽  
M Elze ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document